サマリー

欧州の受託製造市場は、2023年から2030年の予測期間において6.0%の大幅なCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年で、予測期間は2023年から2030年です
市場セグメンテーション
欧州受託製造市場：製品別（医療機器製造、医薬品製造）、エンドユーザー別（相手先ブランド製造会社、医療機器会社、製薬会社、バイオテクノロジー会社、バイオ医薬品会社、研究機関）、流通チャネル（直接入札、小売販売、その他）、国（ドイツ、フランス、イギリス、イタリア、スペイン、オランダ、ロシア、スイス、トルコ、ベルギー、その他ヨーロッパ） 産業動向と2030年までの予測
欧州の受託製造市場の成長に寄与する主な要因としては、以下のようなものが挙げられます：
- ヘルスケア分野における技術的進歩の拡大
- 費用対効果の向上とキープレイヤーのグローバルなプレゼンス
市場のプレーヤー：

欧州の受託製造市場で事業を展開している主なプレイヤーは以下の通りです：

- アエノバグループ
- サーモフィッシャーサイエンティフィック社（Thermo Fisher Scientific, Inc.
- エボニック・インダストリーズ・アグ
- ロンザ
- ベーリンガーインゲルハイムバイオファーマシューティカルズGmbH.
- キャタレント社
- サンファーマシューティカルインダストリー株式会社
- ニプロファーマ株式会社
- ファイザー株式会社（Pfizer Inc.
- レシファームAB
- ヴェター
- TEコネクティビティ
- メルクKGaA
- アルマックグループ
- ジークフリードホールディングAG
- ジュビラント・ファーマ・リミテッド
- アビッドバイオサービシーズ株式会社
- バクスター
- キンブルエレクトロニクス株式会社
- ファマーヘルスケアサービス
- アッヴィー社（AbbVie Inc.

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
1.3 OVERVIEW OF THE EUROPE CONTRACT MANUFACTURING MARKET 42
1.4 CURRENCY AND PRICING 44
1.5 LIMITATIONS 44
1.6 MARKETS COVERED 44
2 MARKET SEGMENTATION 47
2.1 MARKETS COVERED 47
2.2 GEOGRAPHICAL SCOPE 48
2.3 YEARS CONSIDERED FOR THE STUDY 49
2.4 DBMR TRIPOD DATA VALIDATION MODEL 50
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 53
2.6 MULTIVARIATE MODELLING 54
2.7 PRODUCT SEGMENT LIFELINE CURVE 54
2.8 MARKET END USER COVERAGE GRID 55
2.9 DBMR MARKET POSITION GRID 56
2.10 VENDOR SHARE ANALYSIS 57
2.11 SECONDARY SOURCES 58
2.12 ASSUMPTIONS 58
3 EXECUTIVE SUMMARY 59
4 PREMIUM INSIGHTS 61
4.1 PESTEL ANALYSIS 62
4.2 PORTER'S FIVE FORCES 63
4.3 STRATEGIC INITIATIVES: 64
5 REGULATORY FRAMEWORK 65
5.1 REGULATORY SCENARIO BY FDA 65
5.2 REGULATORY SCENARIO IN AUSTRALIA 66
5.3 REGULATORY SCENARIO IN EUROPE FOR MEDICINES 67
6 MARKET OVERVIEW 68
6.1 DRIVERS 70
6.1.1 COST-EFFECTIVENESS FOR THE MANUFACTURING COMPANIES 70
6.1.2 RISE OF TECHNOLOGICAL ADVANCEMENTS IN CONTRACT MANUFACTURING 70
6.1.3 EUROPE PRESENCE AND CONNECTED NETWORK 71
6.2 RESTRAINTS 71
6.2.1 STRINGENT REGULATIONS AMONG VARIOUS JURISDICTIONS 71
6.2.2 RISK OF CONFIDENTIAL INFORMATION 72
6.3 OPPORTUNITIES 72
6.3.1 PATENT EXPIRY AND INCREASING DEMAND FOR GENERIC DRUGS 72
6.3.2 GROWING EXPENSES ON THE DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE 73
6.3.3 INCREASE IN NUMBER OF STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 73
6.4 CHALLENGES 74
6.4.1 INTELLECTUAL PROPERTY RISKS 74
6.4.2 INCREASE IN NUMBER OF PHARMACEUTICAL COMPANIES TO SET UP THEIR MANUFACTURING SITES 74
7 EUROPE CONTRACT MANUFACTURING MARKET, BY PRODUCT 75
7.1 OVERVIEW 76
7.2 PHARMACEUTICAL PRODUCTS MANUFACTURING 79
7.2.1 TYPES OF PRODUCTS 80
7.2.1.1 TABLETS 80
7.2.1.2 CAPSULES 80
7.2.1.3 BIOLOGICS 81
7.2.1.4 SMALL MOLECULE 81
7.2.1.5 CELL & GENES MANUFACTURING 81
7.2.1.6 NUTRACEUTICALS 81
7.2.1.7 OTHERS 81
7.2.2 TYPE OF SERVICES 81
7.2.2.1 DRUG DEVELOPMENT SERVICES 82
7.2.2.2 TABLET MANUFACTURING SERVICES 82
7.2.2.3 BIOLOGICS API MANUFACTURING 82
7.2.2.4 BIOLOGICS FDF MANUFACTURING SERVICES 82
7.2.2.5 OTHERS 82
7.2.3 BY DOSAGE FORM 82
7.2.3.1 SOLID FORMULATIONS 83
7.2.3.2 LIQUID FORMULATIONS 83
7.2.3.2.1 INJECTABLE 83
7.2.3.2.2 SYRUPS 83
7.2.3.3 SEMI-SOLID FORMULATIONS 83
7.2.3.4 TOPICAL DRUG FORMULATIONS 83
7.2.3.5 OTHERS 83
7.3 MEDICAL DEVICE MANUFACTURING 84
7.3.1 TYPE OF DEVICES 85
7.3.1.1 SYRINGES AND NEEDLES 86
7.3.1.2 INFUSION DEVICES & ADMINISTRATION SETS 86
7.3.1.3 MEDICAL ACCESSORIES, COMPONENTS & CONSUMABLES 86
7.3.1.4 DISPOSABLES 86
7.3.1.5 IVD DEVICES 87
7.3.1.6 CARDIOVASCULAR DEVICES 87
7.3.1.7 DIABETES CARE DEVICES 87
7.3.1.8 GENERAL SURGERY DEVICES 87
7.3.1.9 ORTHOPEDIC DEVICES 87
7.3.1.10 RESPIRATORY DEVICES 87
7.3.1.11 OPHTHALMIC DEVICES 87
7.3.1.12 DENTAL DEVICES 87
7.3.1.13 GYNECOLOGY/UROLOGY DEVICES 87
7.3.1.14 LABORATORY EQUIPMENT 87
7.3.2 TYPE OF SERVICES 88
7.3.2.1 MEDICAL DEVICE DESIGN AND DEVELOPMENT 88
7.3.2.2 DEVICE ASSEMBLY 88
7.3.2.3 REGULATORY ASSISTANCE 88
7.3.2.4 PACKAGING & LABELLING 88
7.3.2.5 STERILIZATION SERVICES 89
7.3.2.6 TRAINING AND VALIDATION 89
7.3.2.7 QUALITY ASSURANCE 89
7.3.2.8 OTHERS 89
7.3.3 BY DEVICE CLASS 89
7.3.3.1 CLASS I MEDICAL DEVICES 90
7.3.3.2 CLASS IIA MEDICAL DEVICES 90
7.3.3.3 CLASS IIB MEDICAL DEVICES 90
7.3.3.4 CLASS III MEDICAL DEVICES 90
8 EUROPE CONTRACT MANUFACTURING MARKET, BY END USER 91
8.1 OVERVIEW 92
8.2 PHARMACEUTICAL COMPANIES 95
8.3 BIOTECHNOLOGY COMPANIES 95
8.4 BIOPHARMA COMPANIES 96
8.5 MEDICAL DEVICES COMPANIES 97
8.6 ORIGINAL EQUIPMENT MANUFACTURER 97
8.7 RESEARCH INSTITUTES 98
9 EUROPE CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL 99
9.1 OVERVIEW 100
9.2 RETAIL SALES 103
9.3 DIRECT TENDER 104
9.4 OTHERS 105
10 EUROPE CONTRACT MANUFACTURING MARKET, BY REGION 106
10.1 EUROPE 107
10.1.1 GERMANY 120
10.1.2 FRANCE 128
10.1.3 U.K. 136
10.1.4 ITALY 144
10.1.5 SPAIN 152
10.1.6 RUSSIA 160
10.1.7 TURKEY 168
10.1.8 BELGIUM 176
10.1.9 NETHERLANDS 184
10.1.10 SWITZERLAND 192
10.1.11 REST OF EUROPE 200
11 EUROPE CONTRACT MANUFACTURING MARKET: COMPANY LANDSCAPE 201
11.1 COMPANY SHARE ANALYSIS: EUROPE 201
12 SWOT ANALYSIS 202
13 COMPANY PROFILE 203
13.1 AENOVA GROUP 203
13.1.1 COMPANY SNAPSHOT 203
13.1.2 COMPANY SHARE ANALYSIS 203
13.1.3 PRODUCT PORTFOLIO 204
13.1.4 RECENT DEVELOPMENTS 204
13.2 THERMO FISHER SCIENTIFIC INC. 205
13.2.1 COMPANY SNAPSHOT 205
13.2.2 REVENUE ANALYSIS 206
13.2.3 COMPANY SHARE ANALYSIS 206
13.2.4 PRODUCT PORTFOLIO 207
13.2.5 RECENT DEVELOPMENTS 207
13.3 EVONIK INDUSTRIES AG 208
13.3.1 COMPANY SNAPSHOT 208
13.3.2 REVENUE ANALYSIS 208
13.3.3 COMPANY SHARE ANALYSIS 209
13.3.4 PRODUCT PORTFOLIO 209
13.3.5 RECENT DEVELOPMENTS 209
13.4 LONZA 210
13.4.1 COMPANY SNAPSHOT 210
13.4.2 REVENUE ANALYSIS 210
13.4.3 COMPANY SHARE ANALYSIS 211
13.4.4 PRODUCT PORTFOLIO 211
13.4.5 RECENT DEVELOPMENTS 212
13.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH. 213
13.5.1 COMPANY SNAPSHOT 213
13.5.2 REVENUE ANALYSIS 213
13.5.3 COMPANY SHARE ANALYSIS 214
13.5.4 PRODUCT PORTFOLIO 214
13.5.5 RECENT DEVELOPMENTS 214
13.6 ABBVIE INC. 215
13.6.1 COMPANY SNAPSHOT 215
13.6.2 REVENUE ANALYSIS 215
13.6.3 PRODUCT PORTFOLIO 216
13.6.4 RECENT DEVELOPMENT 216
13.7 ALMAC GROUP 217
13.7.1 COMPANY SNAPSHOT 217
13.7.2 PRODUCT PORTFOLIO 217
13.7.3 RECENT DEVELOPMENTS 217
13.8 AVID BIOSERVICES, INC. 218
13.8.1 COMPANY SNAPSHOT 218
13.8.2 REVENUE ANALYSIS 218
13.8.3 PRODUCT PORTFOLIO 219
13.8.4 RECENT DEVELOPMENT 219
13.9 BAXTER 220
13.9.1 COMPANY SNAPSHOT 220
13.9.2 REVENUE ANALYSIS 220
13.9.3 PRODUCT PORTFOLIO 221
13.9.4 RECENT DEVELOPMENTS 222
13.10 CATALENT, INC 223
13.10.1 COMPANY SNAPSHOT 223
13.10.2 REVENUE ANALYSIS 223
13.10.3 PRODUCT PORTFOLIO 224
13.10.4 RECENT DEVELOPMENT 224
13.11 FAMAR HEALTH CARE SERVICES 225
13.11.1 COMPANY SNAPSHOT 225
13.11.2 PRODUCT PORTFOLIO 225
13.11.3 RECENT DEVELOPMENTS 225
13.12 JUBILANT PHARMA LIMITED 226
13.12.1 COMPANY SNAPSHOT 226
13.12.2 REVENUE ANALYSIS 226
13.12.3 PRODUCT PORTFOLIO 227
13.12.4 RECENT DEVELOPMENT 227
13.13 KIMBALL INTERNATIONAL 228
13.13.1 COMPANY SNAPSHOT 228
13.13.2 REVENUE ANALYSIS 228
13.13.3 PRODUCT PORTFOLIO 229
13.13.4 RECENT DEVELOPMENT 229
13.14 MERCK KGAA 230
13.14.1 COMPANY SNAPSHOT 230
13.14.2 REVENUE ANALYSIS 230
13.14.3 PRODUCT PORTFOLIO 231
13.14.4 RECENT DEVELOPMENTS 231
13.15 NIPR0 232
13.15.1 COMPANY SNAPSHOT 232
13.15.2 REVENUE ANALYSIS 232
13.15.3 PRODUCT PORTFOLIO 233
13.15.4 RECENT DEVELOPMENT 233
13.16 PFIZER INC 234
13.16.1 COMPANY SNAPSHOT 234
13.16.2 REVENUE ANALYSIS 234
13.16.3 PRODUCT PORTFOLIO 235
13.16.4 RECENT DEVELOPMENT 235
13.17 RECIPHARM AB. 236
13.17.1 COMPANY SNAPSHOT 236
13.17.2 REVENUE ANALYSIS 236
13.17.3 PRODUCT PORTFOLIO 237
13.17.4 RECENT DEVELOPMENT 237
13.18 SIEGFRIED HOLDING AG 238
13.18.1 COMPANY SNAPSHOT 238
13.18.2 REVENUE ANALYSIS 238
13.18.3 PRODUCT PORTFOLIO 239
13.18.4 RECENT DEVELOPMENTS 239
13.19 SUN PHARMACEUTICAL INDUSTRIES LTD 240
13.19.1 COMPANY SNAPSHOT 240
13.19.2 REVENUE ANALYSIS 240
13.19.3 PRODUCT PORTFOLIO 241
13.19.4 RECENT DEVELOPMENT 241
13.20 TE CONNECTIVITY 242
13.20.1 COMPANY SNAPSHOT 242
13.20.2 REVENUE ANALYSIS 242
13.20.3 PRODUCT PORTFOLIO 243
13.20.4 RECENT DEVELOPMENT 243
13.21 VETTER PHARMA-FERTIGUNG GMBH & CO. KG 244
13.21.1 COMPANY SNAPSHOT 244
13.21.2 PRODUCT PORTFOLIO 244
13.21.3 RECENT DEVELOPMENTS 244
14 QUESTIONNAIRE 245
15 RELATED REPORTS 248

ページTOPに戻る

図表リスト

LIST OF TABLES
TABLE 1 EUROPE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 59
TABLE 2 EUROPE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 60
TABLE 3 EUROPE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 61
TABLE 4 EUROPE TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 61
TABLE 5 EUROPE BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 62
TABLE 6 EUROPE BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 63
TABLE 7 EUROPE LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 64
TABLE 8 EUROPE MEDICAL DEVICE MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 65
TABLE 9 EUROPE CONSUMABLES AND ACCESSORIES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 66
TABLE 10 EUROPE TYPE OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 67
TABLE 11 EUROPE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 69
TABLE 12 EUROPE BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 70
TABLE 13 EUROPE CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 75
TABLE 14 EUROPE PHARMACEUTICAL COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 76
TABLE 15 EUROPE BIOTECHNOLOGY COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 16 EUROPE BIOPHARMA COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 17 EUROPE AMBULATORY SURGICAL CENTERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 18 EUROPE ORIGINAL EQUIPMENT MANUFACTURER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 79
TABLE 19 EUROPE RESEARCH INSTITUTES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 79
TABLE 20 EUROPE CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 83
TABLE 21 EUROPE RETAIL SALES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 84
TABLE 22 EUROPE DIRECT TENDER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 85
TABLE 23 EUROPE OTHERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 86
TABLE 24 EUROPE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 92
TABLE 25 EUROPE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 92
TABLE 26 EUROPE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 92
TABLE 27 EUROPE TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 93
TABLE 28 EUROPE TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (UNIT) 93
TABLE 29 EUROPE TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (ASP) 94
TABLE 30 EUROPE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 94
TABLE 31 EUROPE BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 94
TABLE 32 EUROPE LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 95
TABLE 33 EUROPE MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 95
TABLE 34 EUROPE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 96
TABLE 35 EUROPE TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 97
TABLE 36 EUROPE TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 98
TABLE 37 EUROPE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 99
TABLE 38 EUROPE BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 99
TABLE 39 EUROPE CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 100
TABLE 40 EUROPE CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 100
TABLE 41 GERMANY CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101
TABLE 42 GERMANY PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101
TABLE 43 GERMANY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101
TABLE 44 GERMANY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 102
TABLE 45 GERMANY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 102
TABLE 46 GERMANY BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103
TABLE 47 GERMANY BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103
TABLE 48 GERMANY LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103
TABLE 49 GERMANY MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 104
TABLE 50 GERMANY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 104
TABLE 51 GERMANY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 105
TABLE 52 GERMANY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 106
TABLE 53 GERMANY TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 107
TABLE 54 GERMANY BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 107
TABLE 55 GERMANY CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 108
TABLE 56 GERMANY CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 108
TABLE 57 FRANCE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109
TABLE 58 FRANCE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109
TABLE 59 FRANCE TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109
TABLE 60 FRANCE TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 110
TABLE 61 FRANCE TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 110
TABLE 62 FRANCE BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111
TABLE 63 FRANCE BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111
TABLE 64 FRANCE LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111
TABLE 65 FRANCE MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 112
TABLE 66 FRANCE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 112
TABLE 67 FRANCE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 113
TABLE 68 FRANCE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 114
TABLE 69 FRANCE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 115
TABLE 70 FRANCE BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 115
TABLE 71 FRANCE CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 116
TABLE 72 FRANCE CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 116
TABLE 73 U.K. CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117
TABLE 74 U.K. PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117
TABLE 75 U.K. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117
TABLE 76 U.K. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 118
TABLE 77 U.K. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 118
TABLE 78 U.K. BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119
TABLE 79 U.K. BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119
TABLE 80 U.K. LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119
TABLE 81 U.K. MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 120
TABLE 82 U.K. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 120
TABLE 83 U.K. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 121
TABLE 84 U.K. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 122
TABLE 85 U.K. TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 123
TABLE 86 U.K. BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 123
TABLE 87 U.K. CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 124
TABLE 88 U.K. CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 124
TABLE 89 ITALY CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 125
TABLE 90 ITALY PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 125
TABLE 91 ITALY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 125
TABLE 92 ITALY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 126
TABLE 93 ITALY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 126
TABLE 94 ITALY BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 127
TABLE 95 ITALY BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 127
TABLE 96 ITALY LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 127
TABLE 97 ITALY MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 128
TABLE 98 ITALY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 128
TABLE 99 ITALY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 129
TABLE 100 ITALY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 130
TABLE 101 ITALY TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 131
TABLE 102 ITALY BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 131
TABLE 103 ITALY CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 132
TABLE 104 ITALY CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 132
TABLE 105 SPAIN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 133
TABLE 106 SPAIN PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 133
TABLE 107 SPAIN TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 133
TABLE 108 SPAIN TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 134
TABLE 109 SPAIN TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 134
TABLE 110 SPAIN BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 135
TABLE 111 SPAIN BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 135
TABLE 112 SPAIN LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 135
TABLE 113 SPAIN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 136
TABLE 114 SPAIN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 136
TABLE 115 SPAIN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 137
TABLE 116 SPAIN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 138
TABLE 117 SPAIN TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 139
TABLE 118 SPAIN BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 139
TABLE 119 SPAIN CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 140
TABLE 120 SPAIN CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 140
TABLE 121 RUSSIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 141
TABLE 122 RUSSIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 141
TABLE 123 RUSSIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 141
TABLE 124 RUSSIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 142
TABLE 125 RUSSIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 142
TABLE 126 RUSSIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 143
TABLE 127 RUSSIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 143
TABLE 128 RUSSIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 143
TABLE 129 RUSSIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 144
TABLE 130 RUSSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 144
TABLE 131 RUSSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 145
TABLE 132 RUSSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 146
TABLE 133 RUSSIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 147
TABLE 134 RUSSIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 147
TABLE 135 RUSSIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 148
TABLE 136 RUSSIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 148
TABLE 137 TURKEY CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 149
TABLE 138 TURKEY PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 149
TABLE 139 TURKEY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 149
TABLE 140 TURKEY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 150
TABLE 141 TURKEY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 150
TABLE 142 TURKEY BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 151
TABLE 143 TURKEY BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 151
TABLE 144 TURKEY LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 151
TABLE 145 TURKEY MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 152
TABLE 146 TURKEY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 152
TABLE 147 TURKEY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 153
TABLE 148 TURKEY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 154
TABLE 149 TURKEY TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 155
TABLE 150 TURKEY BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 155
TABLE 151 TURKEY CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 156
TABLE 152 TURKEY CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 156
TABLE 153 BELGIUM CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 157
TABLE 154 BELGIUM PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 157
TABLE 155 BELGIUM TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 157
TABLE 156 BELGIUM TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 158
TABLE 157 BELGIUM TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 158
TABLE 158 BELGIUM BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 159
TABLE 159 BELGIUM BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 159
TABLE 160 BELGIUM LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 159
TABLE 161 BELGIUM MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 160
TABLE 162 BELGIUM TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 160
TABLE 163 BELGIUM TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 161
TABLE 164 BELGIUM TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 162
TABLE 165 BELGIUM TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 163
TABLE 166 BELGIUM BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 163
TABLE 167 BELGIUM CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 164
TABLE 168 BELGIUM CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 164
TABLE 169 NETHERLANDS CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 165
TABLE 170 NETHERLANDS PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 165
TABLE 171 NETHERLANDS TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 165
TABLE 172 NETHERLANDS TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 166
TABLE 173 NETHERLANDS TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 166
TABLE 174 NETHERLANDS BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 167
TABLE 175 NETHERLANDS BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 167
TABLE 176 NETHERLANDS LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 167
TABLE 177 NETHERLANDS MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 168
TABLE 178 NETHERLANDS TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 168
TABLE 179 NETHERLANDS TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 169
TABLE 180 NETHERLANDS TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 170
TABLE 181 NETHERLANDS TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 171
TABLE 182 NETHERLANDS BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 171
TABLE 183 NETHERLANDS CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 172
TABLE 184 NETHERLANDS CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 172
TABLE 185 SWITZERLAND CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 173
TABLE 186 SWITZERLAND PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 173